Virtus Fund Advisers’s CytomX Therapeutics CTMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
$339K Buy
+16,059
New +$339K ﹤0.01% 421